News

Peripheral vascular embolization solution developer Instylla announced today that it appointed Sean Boyle as its new CEO.
ABBOTT PARK, Ill., Sept. 2, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that it has acquired Walk Vascular, LLC, a commercial-stage medical device company with a minimally invasive ...
Stryker’s financials revealed total sales of $3.7bn in its medical surgery and neurotechnology business unit, up 17.3% on Q2 ...
The Stealth 360 ® Peripheral Orbital Atherectomy System (OAS) received CE Mark in October 2014. As of June 30, 2018, over 392,000 of CSI’s devices have been sold to leading institutions across ...
WAYNE, Pa.--(BUSINESS WIRE)--Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced Food and Drug Administration PMA approval ...
The ARROW Endurance Extended Dwell Peripheral Catheter System allows healthcare providers access to a patient’s peripheral vascular system for short-term use to sample blood, monitor blood ...
WAYNE, Pa - Intact Vascular, Inc., a private medical device company committed to developing solutions for minimally invasive peripheral vascular procedures, today announced it received U.S. Food and ...
The FDA has designated a recall of a peripheral catheter system as class I, the most serious kind. Teleflex and its subsidiary Arrow International recalled the system (Arrow Endurance Extended ...
Global Peripheral Vascular Devices Market Segmentation This report by Medi-Tech Insights provides the size of the global peripheral vascular devices market at the regional- and country-level from 2023 ...
Vantis Vascular has completed the first commercial application of its CrossFAST Integrated Microcatheter Advanced Delivery System. The procedures were carried out during a series of complex high ...
Cardiovascular Systems, Inc.CSII recently announced the first global commercial use of its minimally-invasive Stealth 360Peripheral Orbital Atherectomy System (OAS) in Hong Kong. Stealth 360 OAS ...